Drug Resistance

Drug resistance remains one of the greatest challenges in oncology, often leading to treatment failure and cancer relapse. Tumors can develop resistance through a myriad of methods: genetic mutations, pathway reactivation, or adaptation within the tumor microenvironment. To understand the mechanisms behind drug resistance and evaluate new treatment strategies require advanced preclinical models that accurately reflect drug resistance patterns.


GemPharmatech offers a wide range of genetically engineered mouse models and custom tumor resistance models that enable researchers to study primary and acquired resistance across various cancer types. GemPharmatech also offers preclinical services such as with in vivo efficacy, combination therapy testing, and tissue analysis to support you on your journey to uncover, overcome or prevent drug resistance.


1c6045e1-60b6-4bbb-835a-7bda03a4eb03.jpeg


Need help with your drug resistance study? Contact us and let our team of experts help you.